Nath Bio-Genes (India) (NSE:NATHBIOGEN) Cyclically Adjusted Book per Share: ₹0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NATHBIOGEN Nath Bio-Genes (India) Ltd NSE:NATHBIOGEN
73 GF Score
Price ₹154.63
GF Value ₹264.52
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Nath Bio-Genes (India) Cyclically Adjusted Book per Share?

Nath Bio-Genes (India) NSE:NATHBIOGEN -1.60% 73 Cyclically Adjusted Book per Share is ₹0.00 as of Jun. 2026. GuruFocus rates NSE:NATHBIOGEN with a GF Score™ of 73/100 and a GF Value™ of ₹264.52 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Nath Bio-Genes (India)'s adjusted book value per share for the three months ended in Jun. 2026 was ₹0.000. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Nath Bio-Genes (India)'s average Cyclically Adjusted Book Growth Rate was 14.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Nath Bio-Genes (India) was 10.50% per year. The lowest was 10.00% per year. And the median was 10.25% per year.

As of today (2026-08-13), Nath Bio-Genes (India)'s current stock price is ₹154.63. Nath Bio-Genes (India)'s Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was ₹0.00. Nath Bio-Genes (India)'s Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Nath Bio-Genes (India) was 1.19. The lowest was 0.44. And the median was 0.73.


Nath Bio-Genes (India)  (NSE:NATHBIOGEN) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Nath Bio-Genes (India) was 1.19. The lowest was 0.44. And the median was 0.73.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Nath Bio-Genes (India) Cyclically Adjusted Book per Share Related Terms


Nath Bio-Genes (India) Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Nath Bio-Genes (India)'s Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nath Bio-Genes (India) Cyclically Adjusted Book per Share Chart

Nath Bio-Genes (India) Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 207.10 232.52 256.56 275.80 318.04

Nath Bio-Genes (India) Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 300.70 0.00 318.04 0.00

NSE:NATHBIOGEN vs CTVA, CF, MOS: Cyclically Adjusted Book per Share Comparison

For the Agricultural Inputs subindustry, Nath Bio-Genes (India)'s Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nath Bio-Genes (India) Cyclically Adjusted PB Ratio vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Nath Bio-Genes (India)'s Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Nath Bio-Genes (India)'s Cyclically Adjusted PB Ratio falls into.


NSE:NATHBIOGEN
73GF Score
Nath Bio-Genes (India) Ltd NSE:NATHBIOGEN
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nath Bio-Genes (India) Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nath Bio-Genes (India)'s adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/166.1454*166.1454
=0.000

Current CPI (Jun. 2026) = 166.1454.

Nath Bio-Genes (India) Quarterly Data

Book Value per Share CPI Adj_Book
201609 86.601 105.961 135.789
201612 87.334 105.196 137.934
201703 189.523 105.196 299.331
201706 98.576 107.109 152.910
201709 100.818 109.021 153.644
201712 0.000 109.404 0.000
201803 246.912 109.786 373.665
201806 0.000 111.317 0.000
201809 262.759 115.142 379.151
201812 0.000 115.142 0.000
201903 267.092 118.202 375.426
201906 0.000 120.880 0.000
201909 287.586 123.175 387.912
201912 0.000 126.235 0.000
202003 293.421 124.705 390.927
202006 0.000 127.000 0.000
202009 316.717 130.118 404.411
202012 0.000 130.889 0.000
202103 322.710 131.771 406.895
202106 0.000 134.084 0.000
202109 344.991 135.847 421.935
202112 0.000 138.161 0.000
202203 285.165 138.822 341.293
202206 0.000 142.347 0.000
202209 300.144 144.661 344.720
202212 0.000 145.763 0.000
202303 301.607 146.865 341.203
202306 0.000 150.280 0.000
202309 317.852 151.492 348.597
202312 0.000 152.924 0.000
202403 320.942 153.035 348.438
202406 0.000 155.789 0.000
202409 336.915 157.882 354.548
202412 0.000 158.323 0.000
202503 339.080 157.552 357.575
202506 0.000 159.755 0.000
202509 357.742 162.289 366.242
202512 0.000 163.281 0.000
202603 358.061 164.272 362.144
202606 0.000 166.145 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₹0.00 mean?
Nath Bio-Genes (India) (NSE:NATHBIOGEN) has a Cyclically Adjusted Book per Share of ₹0.00 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Nath Bio-Genes (India) and its competitors.
Is Nath Bio-Genes (India)'s Cyclically Adjusted Book per Share too high?
Nath Bio-Genes (India)'s current Cyclically Adjusted Book per Share is ₹0.00. Overall, Nath Bio-Genes (India) has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nath Bio-Genes (India)'s Cyclically Adjusted Book per Share compare to CTVA and CF?
Nath Bio-Genes (India)'s Cyclically Adjusted Book per Share of ₹0.00 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for an Agriculture company?
A good Cyclically Adjusted Book per Share depends on the Agriculture industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Nath Bio-Genes (India) and its competitors. Nath Bio-Genes (India)'s current Cyclically Adjusted Book per Share is ₹0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nath Bio-Genes (India) stock overvalued right now?
Based on GuruFocus' analysis, Nath Bio-Genes (India) (NSE:NATHBIOGEN) is currently considered Possible Value Trap. The stock's GF Value™ is ₹264.52, compared to a current price of ₹154.63 — trading 41.5% below its estimated fair value. The current Cyclically Adjusted Book per Share is ₹0.00. Nath Bio-Genes (India)'s overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Nath Bio-Genes (India) (NSE:NATHBIOGEN), the current Cyclically Adjusted Book per Share is ₹0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) Overvalued in 2026?

Based on GuruFocus' analysis, Nath Bio-Genes (India) stock appears to be undervalued. The current stock price of ₹154.63 is trading 41.5% below its estimated GF Value™ of ₹264.52. GuruFocus considers Nath Bio-Genes (India) to be Possible Value Trap.

Key valuation signals for NSE:NATHBIOGEN:

  • Cyclically Adjusted Book per Share: ₹0.00
  • GF Value™: ₹264.52 vs. price of ₹154.63 (41.5% below fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the NSE:NATHBIOGEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nath Bio-Genes (India) Business Description

Other Exchanges 537291:India
Address 86, Veer Nariman Road, 1, Chateau Windsor, Churchgate, Mumbai, MH, IND, 400 020
Nath Bio-Genes (India) Ltd is engaged in the business of production, processing, and marketing of Hybrid and GM seeds. The company has a product range of field crops, vegetable crops, and micronutrient supplements. It has developed products across verticals of cotton, paddy, mustard, maize, okra, tomato, gourds, chili, and crop nutrition supplements. The operating segments of the group are Agriculture activities; and Trading activities, of which a majority of revenue is derived from the Agriculture activities segment. Geographically, the group has a business presence in India and other countries, of which key revenue is generated within India.
73GF Score

Get the complete analysis for NSE:NATHBIOGEN

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹154.63
Price
₹264.52
GF Value